KARALYN CHAMPION: Open Payments
NPI 1124403159 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 18 payments from 11 companies in 2025. Trend: 2023 $568 · 2024 $955 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $84 |
| CeQur Corporation | 1 | $69 |
| Medtronic, Inc. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Abbott Laboratories | 1 | $27 |
| BETA BIONICS, INC. | 1 | $25 |
| ABBVIE INC. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| KYOWA KIRIN, INC. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
Products named: CeQur Simplicity, Rybelsus, MINIMED 780G, Kerendia, Ozempic, FREESTYLE LIBRE 3, iLet Bionic Pancreas, SYNTHROID.
Industry payments across CA — which companies pay providers there.
